1. Home
  2. RENE vs MYO Comparison

RENE vs MYO Comparison

Compare RENE & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENE
  • MYO
  • Stock Information
  • Founded
  • RENE 2021
  • MYO 2004
  • Country
  • RENE United States
  • MYO United States
  • Employees
  • RENE N/A
  • MYO N/A
  • Industry
  • RENE Blank Checks
  • MYO Industrial Specialties
  • Sector
  • RENE Finance
  • MYO Health Care
  • Exchange
  • RENE Nasdaq
  • MYO Nasdaq
  • Market Cap
  • RENE 153.8M
  • MYO 153.0M
  • IPO Year
  • RENE 2022
  • MYO 2017
  • Fundamental
  • Price
  • RENE $11.91
  • MYO $3.22
  • Analyst Decision
  • RENE
  • MYO Strong Buy
  • Analyst Count
  • RENE 0
  • MYO 4
  • Target Price
  • RENE N/A
  • MYO $9.50
  • AVG Volume (30 Days)
  • RENE 149.6K
  • MYO 442.3K
  • Earning Date
  • RENE 01-01-0001
  • MYO 05-07-2025
  • Dividend Yield
  • RENE N/A
  • MYO N/A
  • EPS Growth
  • RENE N/A
  • MYO N/A
  • EPS
  • RENE 0.40
  • MYO N/A
  • Revenue
  • RENE N/A
  • MYO $38,628,624.00
  • Revenue This Year
  • RENE N/A
  • MYO $57.44
  • Revenue Next Year
  • RENE N/A
  • MYO $21.76
  • P/E Ratio
  • RENE $29.60
  • MYO N/A
  • Revenue Growth
  • RENE N/A
  • MYO 97.60
  • 52 Week Low
  • RENE $11.22
  • MYO $2.76
  • 52 Week High
  • RENE $11.95
  • MYO $7.17
  • Technical
  • Relative Strength Index (RSI)
  • RENE 51.16
  • MYO 26.65
  • Support Level
  • RENE $11.85
  • MYO $4.65
  • Resistance Level
  • RENE $11.93
  • MYO $4.87
  • Average True Range (ATR)
  • RENE 0.01
  • MYO 0.28
  • MACD
  • RENE -0.00
  • MYO -0.11
  • Stochastic Oscillator
  • RENE 60.40
  • MYO 3.28

About RENE Cartesian Growth Corporation II

Cartesian Growth Corp II is a blank check company.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: